Head-to-head · Cost-Efficiency Index
AbundRX vs FeelGood
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
AbundRX
Cost-first shoppers, with the caveat that the advertised price's time period is unconfirmed.
Visit AbundRXFeelGood
Cost-first shoppers who want a low compounded-injection entry price with an oral tablet alternative for needle-averse shoppers.
Visit FeelGoodThe verdict
AbundRX and FeelGood tie on the Cost-Efficiency Index at 65/100, so neither wins outright on the numbers. For most shoppers we'd start with AbundRX (ranked #157, a hair above #162) — Cost-first shoppers, with the caveat that the advertised price's time period is unconfirmed. But FeelGood is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs AbundRX.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | AbundRX | FeelGood |
|---|---|---|
| Cost-Efficiency Index | 65/100 | 65/100 |
| Semaglutide / mo | $99/mo (starting dose, compounded) | Not disclosed |
| Tirzepatide / mo | $149/mo (starting dose, compounded) | $149/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $1,188 | — |
| Tirzepatide / yr (modeled) | $1,788 | $1,788 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Yes |
| Rank here | #157 | #162 |
AbundRX
65/100Where the value is
- LegitScript certification badge confirmed present on the live homepage
- Simple, fast online health assessment with two clear compounded GLP-1 pathways
- Genuinely low advertised entry price ($99 semaglutide / $149 tirzepatide) as verified directly from the site's own product cards — cheaper than the figure currently on file
The tradeoffs
- The site does not state whether '$99'/'$149' is a monthly, one-time, or first-order price — no duration label appears anywhere near either figure
- No dose amount or supply quantity is disclosed for either price
FeelGood
65/100Where the value is
- Low advertised compounded-injection entry price ($149/mo) with no stated membership or hidden fees
- Oral/dissolvable tablet option available for needle-averse patients ($249/mo)
- Free shipping and HSA/FSA eligibility stated plainly on the homepage
The tradeoffs
- Per-dose pricing, states served, named medical director, and named compounding pharmacy are all gated behind the intake questionnaire — none are disclosed on the public site, so I could not independently verify them
- It is unclear from the public site whether tirzepatide is priced the same as semaglutide or separately
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.